Patents Represented by Attorney, Agent or Law Firm Jaye McLaughlin
  • Isolated mammalian membrane protein genes; related reagents
    Patent number: 6277959
    Abstract: Nucleic acids encoding various lymphocyte cell proteins from mammalian, including primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: August 21, 2001
    Assignee: Schering Corporation
    Inventors: Jenny Valladeau, Odile Ravel, Elizabeth Esther Mary Bates, John Ford, Sem Saeland, Serge J. E. Lebecque
  • RAS converting endoprotease (RCE) and methods
    Patent number: 6261793
    Abstract: The present invention provides human ras converting endoprotease (RCE), the encoding nucleic acids, recombinant vectors, transformed host cells and methods of making human RCE. More particularly, the invention provides methods of using human RCE in screening systems to identify inhibitors of human RCE useful for the treatment of various medical conditions. This invention further relates to inhibitors of human RCE.
    Type: Grant
    Filed: March 4, 1999
    Date of Patent: July 17, 2001
    Assignee: Schering Corporation
    Inventors: David Whyte, Marnie McGuirk, Irma Nuñez-Oliva, Tish Hockenberry, James Pai
  • Method for enhancing the antibody response to specific antigens with Interleukin-10
    Patent number: 5866134
    Abstract: A method for enhancing the immune response of a mammal to a vaccine comprising administering to such a mammal an effective amount of IL-10 in conjunction with the vaccine. A pharmaceutical composition comprised of an effective amount of IL-10, a natural, synthetic or recombinant antigen and a pharmaceutcally acceptable carrier.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: February 2, 1999
    Assignee: Schering Corporation
    Inventors: Jay S. Fine, Michael J. Grace